ACRS — Aclaris Therapeutics, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1557746 ·
Last close
$6.31
Market Cap
$928.83M
52W High
$6.51
52W Low
$4.07
ADV30
1,909,054
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,629,000 | 176,000 | -23,938,000 | -21,505,000 | 179,693,000 | 19,167,000 | 55,112,000 |
| Mar 2026 | 1,996,000 | 208,000 | -22,192,000 | -19,824,000 | 198,720,000 | 28,660,000 | 55,071,000 |
| Dec 2025 | 1,295,000 | -174,000 | -21,029,000 | -19,795,000 | 160,460,000 | 19,960,000 | 57,378,000 |
| Sep 2025 | 3,299,000 | 850,000 | -16,333,000 | -14,614,000 | 175,534,000 | 25,256,000 | 55,434,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-62,059,000
Investing CF
$3,530,000
Financing CF
$52,294,000
CapEx
$-118,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.58
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,009,113,000
Inventory
—
Receivables
$4,680,000
ST Investments
$72,389,000
EBIT TTM
$-85,513,000
Pretax Income TTM
$-75,738,000
Interest Exp TTM
—
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,219,000
EBITDA
$-85,525,000
Free Cash Flow
$-41,970,624
Enterprise Value
$853,838,912
Total Cash
$91,556,000
Total Debt
$1,850,000
Shares Out
147,198,893
Trailing EPS
$-0.58
Book Value
$0.89
ROE
-59.1%
ROA
-29.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,826,000 | -74,075,000 | -64,923,000 | 160,460,000 | 57,378,000 | — | -47,113,000 |
| Dec 2024 | 18,720,000 | -52,527,000 | -132,065,000 | 220,327,000 | 64,773,000 | — | -20,075,000 |
| Dec 2023 | 31,249,000 | -116,314,000 | -88,481,000 | 197,405,000 | 40,226,000 | — | -78,325,000 |
| Dec 2022 | 29,752,000 | -85,154,000 | -86,908,000 | 254,596,000 | 56,975,000 | — | -67,567,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.81
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $6.00 · spot: $6.31 · call volume: 230 · put volume: 83
Expected Move to 2026-09-18:
±$1.24
(19.65%) —
implied range
$5.07 –
$7.55
· ATM straddle on $6.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CLYM | Climb Bio, Inc. | $941.95M | $16.40 | — |
| AMPH | Amphastar Pharmaceuticals, Inc. | $915.42M | $21.52 | — |
| OLMA | Olema Pharmaceuticals, Inc. | $912.60M | $10.43 | — |
| HELP | CYBIN INC. | $951.24M | $13.02 | — |
| DSGN | Design Therapeutics, Inc. | $953.12M | $15.23 | — |
News headlines (Yahoo Finance, 1h cache)
Aclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP)
2026-08-06 20:35 · Yahoo
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Tops Revenue Estimates
2026-08-06 12:20 · Yahoo
Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength?
2026-07-01 12:23 · Yahoo
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
2026-06-04 19:02 · Yahoo
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
2026-05-28 12:30 · Yahoo
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
2026-05-08 12:30 · Yahoo
Companies Like Aclaris Therapeutics (NASDAQ:ACRS) Are In A Position To Invest In Growth
2026-05-04 10:04 · Yahoo
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Ant
2026-04-28 10:30 · Yahoo
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026
2026-04-27 20:45 · Yahoo
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 69.2%: Here's is How to Trade
2026-08-10 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.